(Q39757776)

English

Loss of hepatocyte nuclear factor 1alpha function in human hepatocellular adenomas leads to aberrant activation of signaling pathways involved in tumorigenesis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Loss of hepatocyte nuclear factor 1alpha function in human hepatocellular adenomas leads to aberrant activation of signaling pathways involved in tumorigenesis (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Jessica Zucman-Rossi

8

object named as

Jessica Zucman-Rossi

0 references

Paulette Bioulac-Sage

6

object named as

Paulette Bioulac-Sage

0 references

Sandra Rebouissou

object named as

Sandra Rebouissou

2

0 references

Sandrine Imbeaud

object named as

Sandrine Imbeaud

7

0 references

Laura Pelletier

1

object named as

Laura Pelletier

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

author name string

Alain Paris

3

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Estelle Rathahao-Paris

4

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Elisabeth Perdu

5

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

language of work or name

0 references

publication date

1 February 2010

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

51

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

557-566

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Liver-Cell Adenomas Associated with Use of Oral Contraceptives

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23362

21 January 2018

Hepatic Adenomata With Type 1 Glycogen Storage Disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23362

21 January 2018

Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23362

21 January 2018

Bi-allelic inactivation of TCF1 in hepatic adenomas

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23362

21 January 2018

Hepatocyte nuclear factor-1 alpha gene inactivation: cosegregation between liver adenomatosis and diabetes phenotypes in two maturity-onset diabetes of the young (MODY)3 families.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23362

21 January 2018

Interaction of a liver-specific nuclear factor with the fibrinogen and alpha 1-antitrypsin promoters

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23362

21 January 2018

Control of pancreas and liver gene expression by HNF transcription factors

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23362

21 January 2018

Hepatocyte nuclear factor 1 inactivation results in hepatic dysfunction, phenylketonuria, and renal Fanconi syndrome

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23362

21 January 2018

Hepatocyte nuclear factor-1alpha is an essential regulator of bile acid and plasma cholesterol metabolism

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23362

21 January 2018

Laron dwarfism and non-insulin-dependent diabetes mellitus in the Hnf-1alpha knockout mouse

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23362

21 January 2018

Hnf1alpha (MODY3) controls tissue-specific transcriptional programs and exerts opposed effects on cell growth in pancreatic islets and liver.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23362

21 January 2018

HNF1alpha inactivation promotes lipogenesis in human hepatocellular adenoma independently of SREBP-1 and carbohydrate-response element-binding protein (ChREBP) activation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23362

21 January 2018

Germline hepatocyte nuclear factor 1alpha and 1beta mutations in renal cell carcinomas.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23362

21 January 2018

In vitro aromatic bioactivation of the weak estrogen E(2)alpha and genesis of DNA adducts.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23362

21 January 2018

Increased lipogenesis in cancer cells: new players, novel targets.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23362

21 January 2018

A fatty acid synthase blockade induces tumor cell-cycle arrest by down-regulating Skp2.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23362

21 January 2018

Orlistat is a novel inhibitor of fatty acid synthase with antitumor activity

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23362

21 January 2018

Upstream and downstream of mTOR

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23362

21 January 2018

Dysregulation of the TSC-mTOR pathway in human disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23362

21 January 2018

Mammalian target of rapamycin activation impairs hepatocytic differentiation and targets genes moderating lipid homeostasis and hepatocellular growth

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23362

21 January 2018

RAD001 (everolimus) inhibits tumour growth in xenograft models of human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23362

21 January 2018

mTOR and P70 S6 kinase expression in primary liver neoplasms

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23362

21 January 2018

Vascular remodeling and antitumoral effects of mTOR inhibition in a rat model of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23362

21 January 2018

Pivotal role of mTOR signaling in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23362

21 January 2018

Activation of the Akt/mammalian target of rapamycin/4E-BP1 pathway by ErbB2 overexpression predicts tumor progression in breast cancers

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23362

21 January 2018

Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23362

21 January 2018

Etiology-dependent molecular mechanisms in human hepatocarcinogenesis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23362

21 January 2018

PDGF-BB modulates endothelial proliferation and angiogenesis in vitro via PDGF beta-receptors

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23362

21 January 2018

Complete regression of hepatocellular adenoma after withdrawal of oral contraceptives

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23362

21 January 2018

Hepatic adenomas: analysis of sex steroid receptor status and the Wnt signaling pathway

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23362

21 January 2018

Genotype–phenotype correlation in hepatocellular adenoma: New classification and relationship with HCC

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23362

21 January 2018

Association of CYP1B1 Germ Line Mutations with Hepatocyte Nuclear Factor 1 -Mutated Hepatocellular Adenoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23362

21 January 2018

Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23362

7 January 2021

based on heuristic

inferred from DOI database lookup

Familial liver adenomatosis associated with hepatocyte nuclear factor 1alpha inactivation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23362

7 January 2021

based on heuristic

inferred from DOI database lookup

Liver adenomatosis. An entity distinct from liver adenoma?

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23362

7 January 2021

based on heuristic

inferred from DOI database lookup

Biosynthesis of estradiol-17 beta fatty acyl esters by microsomes derived from bovine liver and adrenals

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23362

7 January 2021

based on heuristic

inferred from DOI database lookup

Protein elongation factor EEF1A2 is a putative oncogene in ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23362

7 January 2021

based on heuristic

inferred from DOI database lookup

Estrogen induction of hepatocellular carcinomas in Armenian hamsters

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23362

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HEP.23362

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

release_vchtncmy75a75jakxu6f7sa52u

1 reference

https://api.fatcat.wiki/v0/release/vchtncmy75a75jakxu6f7sa52u

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39757776&oldid=2089995439"